ABBOT STEWART 4
4 · FATE THERAPEUTICS INC · Filed Jan 17, 2018
Insider Transaction Report
Form 4
ABBOT STEWART
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-16+186,000→ 186,000 totalExercise: $6.55Exp: 2028-01-15→ Common Stock (186,000 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.
- [F2]Not applicable.